Patent · US Active

Prochelators as targeted prodrugs for prostate cancer and methods of making and using same

US11007273B2 · kind B2 · utility

0Cited by
0References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 3, 2018
Grant dateMay 18, 2021
Priority date—
Expiry dateJul 3, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K7/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides prochelators as targeted prodrugs for cancer, such as prostate cancer, and methods of making and using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.